Bio:
Ariel Rava is currently serving as a Postdoctoral Research Fellow at the Harvard Law School’s Program on Corporate Governance. Holding a Ph.D. in Accounting and Information Assurance from the Robert H. Smith School of Business at the University of Maryland, Ariel boasts a comprehensive research portfolio that encompasses areas such as corporate governance, healthcare economics, management guidance, financial reporting quality, cost management, bankruptcy, ESG investing, as well as ambiguity (Knightian Uncertainty) and economic policy uncertainty.
In addition, Ariel possesses an M.A. in Financial Economics and a B.A. in Economics, both from the Hebrew University of Jerusalem. Before transitioning to academia, Ariel garnered valuable professional experience at several prestigious institutions, including the Central Bank of Israel, Israel’s Securities Authority, and the investment banking arm of Giza Singer Even Inc.
Links:
Contact:
Representative Work:
- Job Market Paper – “Cost Shifting in Healthcare: Insights from Organ Procurement Organization Cost Reports”
- “Navigating Global Uncertainty: Do Foreign National Directors Protect US Firms from Supply Chain Disruptions” (with Musa Subasi and Rohan D’Lima)
- R&R at Contemporary Accounting Research
- Featured in the Harvard Law School Forum on Corporate Governance
- “Understanding the Role of Industry, Firm, CEO, and CFO Effects in Financial Reporting Quality: A Hierarchical Linear Modeling Approach” (with Tharindra Ranasinghe and Emanuel Zur)
-
- R&R (2023 plenary session acceptance) at Journal of Accounting, Auditing and Finance
- “Beyond Risk: Voluntary Disclosure Under Ambiguity” (Dissertation)
- “Lost in Transplantation: Evaluating the Efficiency of Organ Procurement in the United States” (with Erkut Ozbay and Emanuel Zur)
